Navigation Links
Relievant Medsystems Appoints Alex M. DiNello as President and Chief Executive Officer
Date:8/23/2011

REDWOOD CITY, Calif., Aug. 23, 2011 /PRNewswire/ -- Relievant Medsystems, Inc., today announced the appointment of Alex DiNello to the position of president and chief executive officer and as a member of the company's board of directors. The Company recently received FDA approval of an Investigational Device Exemption (IDE) to begin its SMART pivotal trial. The Surgical Multi-center Assessment of RF Ablation for the Treatment of Vertebrogenic Back Pain (SMART) trial is a prospective, randomized, double-blind, sham-controlled investigation evaluating the reduction of pain in patients with chronic axial low back pain that is targeting to enroll 200 subjects.

"As a minimally invasive therapy for those who suffer from inadequately treated chronic low back pain, the Intracept System has the potential to significantly and positively affect people's lives," said Mr. DiNello. "I joined the Relievant team because I believe the Intracept System brings a highly innovative, differentiated technology requiring no implant to spine specialists and their millions of patients who suffer from this debilitating and painful condition."

Mr. DiNello brings over 20 years of experience in the medical device industry, including 18 years focusing on spinal therapies and related medical devices. He has extensive product development, clinical, and commercialization experience including over 60 products successfully launched across the globe. Prior to joining Relievant, DiNello served as vice president and general manager for Medtronic Kyphon. Prior to that, he served as vice president of research and development for Medtronic Kyphon. Previous to that, he was vice president of research and development for Abbott Spine. He also served as vice president of strategic development and research and development at DePuy Spine, a Johnson & Johnson company.

"Alex is uniquely suited to lead the company during this critical phase of executing the SMART clinical study and laying the groundwork for successful commercialization in both US and international markets," said Art Taylor, chairman of the board for Relievant Medsystems. "He is deeply versed in spinal pathologies, is well known and regarded by the spine specialist community and has a proven track record of developing and delivering therapeutic devices to the market. We are pleased to have his leadership during this exciting time for the Company."

Relievant Medsystems is a privately held company based in Redwood City, California.  Its Intracept System is a minimally invasive procedure that uses radiofrequency energy delivered through a small access tube into the vertebral body to ablate the basivertebral nerve. The nerve, thought to significantly contribute to chronic low back pain, can no longer generate pain signals following ablation.

Relievant's primary investors include Canaan Partners, Emergent Ventures, Morganthaler Ventures, and ONSET Ventures.


'/>"/>
SOURCE Relievant Medsystems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. RelievantMedsystems Appoints Alex M. DiNello as President and Chief Executive Officer
2. Relievant Medsystems Announces Completion of $20 Million Financing
3. Mercator MedSystems Appoints Neil Desai, Ph.D., to Board of Directors
4. NeoStem Appoints Grant Thornton LLP as New Independent Registered Public Accounting Firm
5. Endo Pharmaceuticals Announces Leadership Change at HealthTronics Subsidiary: Appoints Kelly Huang, Ph.D. New President
6. CVS Caremark Appoints Mark S. Cosby as President of CVS/pharmacy
7. CCS Medical Appoints Michael A. Sicuro as Executive Vice President and Chief Financial Officer
8. Tengion Appoints Diane Jorkasky, M.D., to its Board of Directors
9. Genelux Corporation Appoints Catherine J. Mackey, PhD to Board of Directors
10. Vermillion Appoints Distribution Partner for OVA1® in Israel and the Palestine Territories
11. State Fund Appoints Medical Director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical Systems ... "Company"), which develops, markets and sells medical devices and ... , signed a strategic cooperation agreement with Hongyuan Supply ... Supply Chain") on June 20, 2016, to develop Dehaier,s ... strategic cooperation agreement, Dehaier will leverage Hongyuan Supply Chain,s ...
(Date:6/24/2016)... , June 24, 2016 According ... by Type (Standard Pen Needles, Safety Pen Needles), Needle ... GLP-1, Growth Hormone), Mode of Purchase (Retail, Non-Retail) - ... This report studies the market for the forecast period ... reach USD 2.81 Billion by 2021 from USD 1.65 ...
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June 14 ... The article goes on to state that individuals are now more comfortable seeking to ... operations such as calf and cheek reduction. The Los Angeles area medical group, Beverly ...
(Date:6/24/2016)... ... ... a crisis. Her son James, eight, was out of control. Prone to extreme mood shifts ... upset him, he couldn’t control his emotions,” remembers Marcy. “If there was a knife ... and say he was going to kill them. If we were driving on the ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas ... , AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... People across ... in Genome magazine’s Code Talker Award, an essay contest in which patients and their ... award to be presented at the 2016 National Society of Genetic Counselors (NSGC) Annual ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... The Grove Investment Group (TGIG), has initiated cultivation and processing operations at its ... Vegas and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system ...
Breaking Medicine News(10 mins):